Dosimetry and preliminary human studies of 18F-5-fluorouracil

Int J Nucl Med Biol. 1982;9(1):25-35. doi: 10.1016/0047-0740(82)90071-7.

Abstract

The relative distribution, metabolism and kinetics of 18F containing compounds, following administration of 18F-5-fluorouracil, has been proposed as a prognostic aid in predicting response to 5-fluorouracil chemotherapy. Because 18F has a relatively short physical half-life (t1/2 = 110 min), and the distribution and kinetics of the radiolabeled 5-fluorouracil need to be studied over periods of time that range over several half-lives of the radionuclide, significant quantities of the labeled drug must be administered in order to obtain good counting statistics. The distribution of 18F, following injection of 18F-5-fluorouracil to rats and mice, has been well documented in our previous work. It appears that the distribution of 18F in humans, following administration of 18F-5-fluorouracil is similar to that in rats. We calculated the radiation dose according to the MIRD technique for the eleven main target organs for a reference man. The critical organs, according to these calculations, are the bladder wall, the kidney and the liver, receiving a radiation dose of 729, 184 and 114 mrad per mCi injected, respectively.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Breast Neoplasms / drug therapy
  • Colonic Neoplasms / drug therapy
  • Drug Evaluation
  • Fluorine*
  • Fluorouracil* / therapeutic use
  • Half-Life
  • Humans
  • Kidney / radiation effects
  • Liver / radiation effects
  • Liver Neoplasms / drug therapy
  • Neoplasms, Experimental / drug therapy
  • Prognosis
  • Radiation Dosage
  • Radioisotopes*
  • Rats
  • Tissue Distribution
  • Urinary Bladder / radiation effects

Substances

  • Radioisotopes
  • Fluorine
  • Fluorouracil